Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2016 June;60(2) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2016 June;60(2):117-23

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi
Per citare questo articolo

 

REVIEWS  PET AND GYNECOLOGICAL TUMORS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2016 June;60(2):117-23

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

MRI and FDG-PET/CT imaging in gynecological malignancies: the radiation oncology perspective

Jamina FENNELL 1, 5, Jutta SCHOLBER 1, 5, Anca-L. GROSU 1, 5, Natalja VOLEGOVA-NEHER 1, 5, Karl HENNE 1, 5, Mathias LANGER 2, 5, Philipp T. MEYER 3, 5, Gerald GITSCH 4, 5, Nico BARTL 1, 5

1Department of Radiation Oncology, University Medical Center Freiburg, Germany; 2 Department of Radiology, University Medical Center Freiburg, Germany; 3 Department of Nuclear Medicine, University Medical Center Freiburg, Germany; 4 Department of Gynecology, University Medical Center Freiburg, Germany; 5 German Cancer Consortium (DKTK), Partner Site Freiburg, Germany


PDF


MRI and FDG-PET imaging plays an important role in diagnosis, monitoring and follow-up of gynecological cancer. The goal of this paper was to summarize data of the literature about sensitivity and specificity of MRI and FDG-PET/CT for detection of primary tumor, lymph nodes invasion and metastases in cervix and endometrial cancer and to discuss their implication for radiation treatment planning and monitoring.

inizio pagina